
HSCS
HeartSciences Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
4.300
Open
3.980
VWAP
4.07
Vol
307.49K
Mkt Cap
7.62M
Low
3.710
Amount
1.25M
EV/EBITDA(TTM)
--
Total Shares
655.62K
EV
9.07M
EV/OCF(TTM)
--
P/S(TTM)
849.62
HeartSciences Inc. is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of artificial intelligence-enhanced electrocardiography (AI-ECG) algorithms and is developing AI-ECG solutions to be made available on either a hardware- agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction, which has traditionally only been available through the use of cardiac imaging. The MyoVista also provides conventional ECG information in the same test. It delivers AI-ECG algorithms using existing ECG devices across a hospital or health system.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
--
--
-2.145
-88.6%
--
--
-2.010
-23.86%
--
--
-1.865
-17.84%
Estimates Revision
The market is revising No Change the revenue expectations for HeartSciences Inc. (HSCS) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 17.61%.
Revenue Estimates for FY2025
No Change

0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change

0.00%
In Past 3 Month
Stock Price
Go Up

+17.61%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for HeartSciences Inc (HSCS.O) is -0.51, compared to its 5-year average forward P/E of -1.26. For a more detailed relative valuation and DCF analysis to assess HeartSciences Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
-1.26
Current PE
-0.51
Overvalued PE
-0.28
Undervalued PE
-2.25
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
-0.90
Current EV/EBITDA
-0.90
Overvalued EV/EBITDA
0.06
Undervalued EV/EBITDA
-1.86
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A
5Y Average PS
246.21
Current PS
20.37
Overvalued PS
1300.51
Undervalued PS
-808.09
Financials
Annual
Quarterly
FY2025Q3
YoY :
-100.00%
0.00
Total Revenue
FY2025Q3
YoY :
+55.47%
-2.37M
Operating Profit
FY2025Q3
YoY :
+54.29%
-2.54M
Net Income after Tax
FY2025Q3
YoY :
-16.01%
-2.57
EPS - Diluted
FY2025Q3
YoY :
-23.92%
-1.64M
Free Cash Flow
FY2025Q3
YoY :
-100.00%
N/A
Gross Profit Margin - %
FY2025Q3
YoY :
-100.00%
N/A
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
HSCS News & Events
Events Timeline
2025-06-04 (ET)
2025-06-04
09:02:30
HeartSciences recesives FDA BDD for Aortic Stenosis ECG algorithm

2025-06-03 (ET)
2025-06-03
09:03:11
HeartSciences announces grant by USPTO for ECG assessment of heart function

2025-05-29 (ET)
2025-05-29
09:03:11
HeartSciences signs first MyoVista Insights platform customer

Sign Up For More Events
Sign Up For More Events
News
9.0
06-04NewsfilterHeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
9.0
06-04NASDAQ.COMHeartSciences: FDA Grants Breakthrough Device Designation For Aortic Stenosis ECG Algorithm
3.5
06-03NewsfilterFoundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value
Sign Up For More News
People Also Watch

SOPA
Society Pass Inc
1.250
USD
0.00%

NDRA
ENDRA Life Sciences Inc
6.600
USD
+0.46%

FAMI
Farmmi Inc
1.850
USD
-2.12%

RSLS
ReShape Lifesciences Inc
2.480
USD
-9.16%

WORX
Scworx Corp
0.427
USD
-3.40%

BENF
Beneficient
0.376
USD
-1.05%

HEPA
Hepion Pharmaceuticals Inc
0
USD
-23.27%

REVB
Revelation Biosciences Inc
2.880
USD
-5.26%

STSS
Sharps Technology Inc
6.120
USD
-0.65%

TNFA
TNF Pharmaceuticals Inc
0.117
USD
-11.36%
FAQ

What is HeartSciences Inc (HSCS) stock price today?
The current price of HSCS is 3.94 USD — it has increased 0.25 % in the last trading day.

What is HeartSciences Inc (HSCS)'s business?

What is the price predicton of HSCS Stock?

What is HeartSciences Inc (HSCS)'s revenue for the last quarter?

What is HeartSciences Inc (HSCS)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for HeartSciences Inc (HSCS)'s fundamentals?

How many employees does HeartSciences Inc (HSCS). have?
